Effect of a Dietary Portfolio of Cholesterol-Lowering Foods Given at 2 Levels of Intensity of Dietary Advice on Serum Lipids in Hyperlipidemia: A Randomized Controlled Trial | Cardiology | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.175.212.130. Please contact the publisher to request reinstatement.
1.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).  JAMA. 2001;285(19):2486-249711368702PubMedGoogle ScholarCrossref
2.
Genest J, McPherson R, Frohlich J,  et al.  2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations.  Can J Cardiol. 2009;25(10):567-57919812802PubMedGoogle ScholarCrossref
3.
Betteridge DJ, Dodson PM, Durrington PN,  et al.  Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association.  Postgrad Med J. 1993;69(811):359-3698346130PubMedGoogle ScholarCrossref
4.
Wooley SC, Garner DM. Dietary treatments for obesity are ineffective.  BMJ. 1994;309(6955):655-6568086992PubMedGoogle ScholarCrossref
5.
Ornish D, Scherwitz LW, Billings JH,  et al.  Intensive lifestyle changes for reversal of coronary heart disease.  JAMA. 1998;280(23):2001-20079863851PubMedGoogle ScholarCrossref
6.
Harsha DW, Sacks FM, Obarzanek E,  et al.  Effect of dietary sodium intake on blood lipids: results from the DASH-sodium trial.  Hypertension. 2004;43(2):393-39814707154PubMedGoogle ScholarCrossref
7.
Shai I, Schwarzfuchs D, Henkin Y,  et al; Dietary Intervention Randomized Controlled Trial (DIRECT) Group.  Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet.  N Engl J Med. 2008;359(3):229-24118635428PubMedGoogle ScholarCrossref
8.
Grundy SM, Cleeman JI, Merz CN,  et al; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.  Circulation. 2004;110(2):227-23915249516PubMedGoogle ScholarCrossref
9.
Jenkins DJ, Kendall CW. Plant sterols, health claims and strategies to reduce cardiovascular disease risk.  J Am Coll Nutr. 1999;18(6):559-56210613406PubMedGoogle ScholarCrossref
10.
Jenkins DJ, Kendall CW, Marchie A,  et al.  Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein.  JAMA. 2003;290(4):502-51012876093PubMedGoogle ScholarCrossref
11.
Jenkins DJ, Kendall CW, Marchie A,  et al.  Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants.  Am J Clin Nutr. 2005;81(2):380-38715699225PubMedGoogle Scholar
12.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.  Clin Chem. 1972;18(6):499-5024337382PubMedGoogle Scholar
13.
Fink PC, Römer M, Haeckel R,  et al.  Measurement of proteins with the Behring Nephelometer. A multicentre evaluation.  J Clin Chem Clin Biochem. 1989;27(4):261-2762661713PubMedGoogle Scholar
14.
Kassis AN, Vanstone CA, AbuMweis SS, Jones PJ. Efficacy of plant sterols is not influenced by dietary cholesterol intake in hypercholesterolemic individuals.  Metabolism. 2008;57(3):339-34618249205PubMedGoogle ScholarCrossref
15.
SAS Institute Inc.  SAS/STAT User's Guide . 9.2 ed. Cary, NC: SAS Institute Inc; 2008
16.
Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals.  Circulation. 1991;83(1):356-3621984895PubMedGoogle ScholarCrossref
17.
Mills EJ, Wu P, Chong G,  et al.  Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials.  QJM. 2011;104(2):109-12420934984PubMedGoogle ScholarCrossref
18.
Hu FB, Stampfer MJ, Manson JE,  et al.  Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study.  BMJ. 1998;317(7169):1341-13459812929PubMedGoogle ScholarCrossref
19.
Kris-Etherton PM, Yu-Poth S, Sabaté J, Ratcliffe HE, Zhao G, Etherton TD. Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk.  Am J Clin Nutr. 1999;70(3):(Suppl)  504S-511S10479223PubMedGoogle Scholar
20.
Wolk A, Manson JE, Stampfer MJ,  et al.  Long-term intake of dietary fiber and decreased risk of coronary heart disease among women.  JAMA. 1999;281(21):1998-200410359388PubMedGoogle ScholarCrossref
21.
Liu S, Buring JE, Sesso HD, Rimm EB, Willett WC, Manson JE. A prospective study of dietary fiber intake and risk of cardiovascular disease among women.  J Am Coll Cardiol. 2002;39(1):49-5611755286PubMedGoogle ScholarCrossref
22.
Halton TL, Willett WC, Liu S,  et al.  Low-carbohydrate-diet score and the risk of coronary heart disease in women.  N Engl J Med. 2006;355(19):1991-200217093250PubMedGoogle ScholarCrossref
23.
Zhang X, Shu XO, Gao YT,  et al.  Soy food consumption is associated with lower risk of coronary heart disease in Chinese women.  J Nutr. 2003;133(9):2874-287812949380PubMedGoogle Scholar
24.
Anderson JW, Allgood LD, Lawrence A,  et al.  Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials.  Am J Clin Nutr. 2000;71(2):472-47910648260PubMedGoogle Scholar
25.
Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis.  Am J Clin Nutr. 1999;69(1):30-429925120PubMedGoogle Scholar
26.
Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R.Stresa Workshop Participants.  Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels.  Mayo Clin Proc. 2003;78(8):965-97812911045PubMedGoogle Scholar
27.
Abumweis SS, Barake R, Jones PJH. Plant sterols/stanols as cholesterol lowering agents: a meta-analysis of randomized controlled trials.  Food Nutr Res. 2008;52:19109655PubMedGoogle Scholar
28.
Jenkins DJ, Mirrahimi A, Srichaikul K,  et al.  Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms.  J Nutr. 2010;140(12):2302S-2311S20943954PubMedGoogle ScholarCrossref
29.
Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids.  N Engl J Med. 1995;333(5):276-2827596371PubMedGoogle ScholarCrossref
30.
Huang J, Frohlich J, Ignaszewski AP. The impact of dietary changes and dietary supplements on lipid profile.  Can J Cardiol. 2011;27(4):488-50521801978PubMedGoogle ScholarCrossref
31.
Sabaté J, Oda K, Ros E. Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials.  Arch Intern Med. 2010;170(9):821-82720458092PubMedGoogle ScholarCrossref
32.
Dayton S, Pearce ML, Hashimoto S, Dixon WJ, Tomiyasu U. A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis.  Circulation. 1969;39/40:(suppl II)  1-63Google Scholar
33.
Miettinen M, Turpeinen O, Karvonen MJ, Elosuo R, Paavilainen E. Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes: a twelve-year clinical trial in men and women.  Lancet. 1972;2(7782):835-8384116551PubMedGoogle ScholarCrossref
34.
Turpeinen O. Effect of cholesterol-lowering diet on mortality from coronary heart disease and other causes.  Circulation. 1979;59(1):1-7758101PubMedGoogle ScholarCrossref
35.
Sacks FM, Bray GA, Carey VJ,  et al.  Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates.  N Engl J Med. 2009;360(9):859-87319246357PubMedGoogle ScholarCrossref
36.
Appel LJ, Sacks FM, Carey VJ,  et al; OmniHeart Collaborative Research Group.  Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial.  JAMA. 2005;294(19):2455-246416287956PubMedGoogle ScholarCrossref
37.
Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial.  JAMA. 2005;293(1):43-5315632335PubMedGoogle ScholarCrossref
38.
Ludwig DS. The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease.  JAMA. 2002;287(18):2414-242311988062PubMedGoogle ScholarCrossref
Original Contribution
August 24/31, 2011

Effect of a Dietary Portfolio of Cholesterol-Lowering Foods Given at 2 Levels of Intensity of Dietary Advice on Serum Lipids in Hyperlipidemia: A Randomized Controlled Trial

Author Affiliations

Author Affiliations: Clinical Nutrition and Risk Factor Modification Center (Drs Jenkins, Kendall, Faulkner, de Souza, Bashyam, Josse, and Leiter and Mr Ireland and Mss Patel, Srichaikul, and Abdulnour) and Department of Medicine (Drs Jenkins, Josse, and Leiter), St Michael's Hospital, Toronto, Ontario; Departments of Nutritional Sciences (Drs Jenkins, Kendall, Faulkner, de Souza, Bashyam, Josse, and Leiter and Mr Ireland and Mss Patel and Srichaikul) and Medicine (Drs Jenkins, Josse, and Leiter), University of Toronto, Toronto, Ontario; Richardson Center for Functional Foods and Nutraceuticals, University of Manitoba, Winnipeg (Drs Jones and Ramprasath); Institute of Nutraceuticals and Functional Foods, Laval University, Quebec City, Quebec (Dr Lamarche and Ms Gigleux); Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver (Dr Frohlich and Mss Cermakova, Collier, and Hoshizaki); Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario (Dr de Souza); Institute of Medical Science, University of Toronto, Toronto, Ontario (Ms Abdulnour); and Keenan Research Center of the Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario (Drs Jenkins, Josse, Leiter, and Connelly), Canada.

JAMA. 2011;306(8):831-839. doi:10.1001/jama.2011.1202
Abstract

Context Combining foods with recognized cholesterol-lowering properties (dietary portfolio) has proven highly effective in lowering serum cholesterol under metabolically controlled conditions.

Objective To assess the effect of a dietary portfolio administered at 2 levels of intensity on percentage change in low-density lipoprotein cholesterol (LDL-C) among participants following self-selected diets.

Design, Setting, and Participants A parallel-design study of 351 participants with hyperlipidemia from 4 participating academic centers across Canada (Quebec City, Toronto, Winnipeg, and Vancouver) randomized between June 25, 2007, and February 19, 2009, to 1 of 3 treatments lasting 6 months.

Intervention Participants received dietary advice for 6 months on either a low− saturated fat therapeutic diet (control) or a dietary portfolio, for which counseling was delivered at different frequencies, that emphasized dietary incorporation of plant sterols, soy protein, viscous fibers, and nuts. Routine dietary portfolio involved 2 clinic visits over 6 months and intensive dietary portfolio involved 7 clinic visits over 6 months.

Main Outcome Measures Percentage change in serum LDL-C.

Results In the modified intention-to-treat analysis of 345 participants, the overall attrition rate was not significantly different between treatments (18% for intensive dietary portfolio, 23% for routine dietary portfolio, and 26% for control; Fisher exact test, P = .33). The LDL-C reductions from an overall mean of 171 mg/dL (95% confidence interval [CI], 168-174 mg/dL) were −13.8% (95% CI, −17.2% to −10.3%; P < .001) or −26 mg/dL (95% CI, −31 to −21 mg/dL; P < .001) for the intensive dietary portfolio; −13.1% (95% CI, −16.7% to −9.5%; P < .001) or –24 mg/dL (95% CI, −30 to −19 mg/dL; P < .001) for the routine dietary portfolio; and −3.0% (95% CI, −6.1% to 0.1%; P = .06) or −8 mg/dL (95% CI, −13 to −3 mg/dL; P = .002) for the control diet. Percentage LDL-C reductions for each dietary portfolio were significantly more than the control diet (P < .001, respectively). The 2 dietary portfolio interventions did not differ significantly (P = .66). Among participants randomized to one of the dietary portfolio interventions, percentage reduction in LDL-C on the dietary portfolio was associated with dietary adherence (r = −0.34, n = 157, P < .001).

Conclusion Use of a dietary portfolio compared with the low−saturated fat dietary advice resulted in greater LDL-C lowering during 6 months of follow-up.

Trial Registration clinicaltrials.gov Identifier: NCT00438425

×